Here are five notes:
1. In February, K2M’s short interest totaled 949,400 shares.
2. Short sellers will need five days to cover their K2M’s short positions.
3. On Feb. 12, the stock increased 1.37 percent to $11.88.
4. Since July 10, 2015, K2M has decreased 48.93 percent.
5. K2M has underperformed the S&P500 by 38.72 percent.
More articles on devices:
Mesoblast cell therapy shows positive results for patients with rheumatoid arthritis — 5 points
Smith & Nephew target of a large growth in short interest — 4 observations
43 spine, orthopedic devices receive FDA 510(k) clearance in January
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
